Share Email Print

Proceedings Paper

The evolution of phase holographic imaging from a research idea to publicly traded company
Author(s): Peter Egelberg
Format Member Price Non-Member Price
PDF $17.00 $21.00

Paper Abstract

Recognizing the value and unmet need for label-free kinetic cell analysis, Phase Holograhic Imaging defines its market segment as automated, easy to use and affordable time-lapse cytometry. The process of developing new technology, meeting customer expectations, sources of corporate funding and R&D adjustments prompted by field experience will be reviewed. Additionally, it is discussed how relevant biological information can be extracted from a sequence of quantitative phase images, with negligible user assistance and parameter tweaking, to simultaneously provide cell culture characteristics such as cell growth rate, viability, division rate, mitosis duration, phagocytosis rate, migration, motility and cell-cell adherence without requiring any artificial cell manipulation.

Paper Details

Date Published: 23 February 2018
PDF: 8 pages
Proc. SPIE 10503, Quantitative Phase Imaging IV, 105030V (23 February 2018); doi: 10.1117/12.2290078
Show Author Affiliations
Peter Egelberg, Phase Holographic Imaging AB (Sweden)

Published in SPIE Proceedings Vol. 10503:
Quantitative Phase Imaging IV
Gabriel Popescu; YongKeun Park, Editor(s)

© SPIE. Terms of Use
Back to Top